[2-(4-methoxy-phenyl)-5-methyl-oxazol-4-yl]-acetic acid | 136058-68-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: [2-(4-methoxy-phenyl)-5-methyl-oxazol-4-yl]-acetic acid
• 英文别名: 2-p-Methoxyphenyl-4-carboxymethyl-5-methyloxazole；2-[2-(4-methoxyphenyl)-5-methyl-1,3-oxazol-4-yl]acetic Acid
• CAS: 136058-68-9
• 化学式: C₁₃H₁₃NO₄
• 分子量: 247.251
• InChiKey: AKJCQPKXTTTWCR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  72.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  [2-(4-methoxy-phenyl)-5-methyl-oxazol-4-yl]-acetic acid 在 硼烷四氢呋喃络合物 、 甲醇 作用下， 以 四氢呋喃 为溶剂， 反应 5.0h， 生成 2-[2-(4-methoxyphenyl)-5-methyl-oxazol-4-yl]-ethanol
  参考文献：
  名称：

  Application of the Dakin−West Reaction for the Synthesis of Oxazole-Containing Dual PPARα/γ Agonists

  摘要：

  An improved method for the preparation of a series of oxazole-containing dual PPARalpha/gamma agonists is described. A synthetic sequence utilizing a Dakin-West reaction was devised that allows for the introduction of the oxazole ring either late in the synthetic sequence via aminomalonate-derived chemistry or in pivotal SAR intermediates derived from aspartic acid.

  DOI：

  10.1021/jo026655v
• 作为产物：
  描述：

  [2-(4-methoxy-phenyl)-5-methyl-oxazol-4-yl]-acetic acid benzyl ester 在 氢氧化钾 作用下， 以 乙醇 、 水 为溶剂， 反应 1.0h， 生成 [2-(4-methoxy-phenyl)-5-methyl-oxazol-4-yl]-acetic acid
  参考文献：
  名称：

  Application of the Dakin−West Reaction for the Synthesis of Oxazole-Containing Dual PPARα/γ Agonists

  摘要：

  An improved method for the preparation of a series of oxazole-containing dual PPARalpha/gamma agonists is described. A synthetic sequence utilizing a Dakin-West reaction was devised that allows for the introduction of the oxazole ring either late in the synthetic sequence via aminomalonate-derived chemistry or in pivotal SAR intermediates derived from aspartic acid.

  DOI：

  10.1021/jo026655v

文献信息

• Oxazolidinedione hypoglycemic agents
  申请人：Pfizer Inc.

  公开号：US05498621A1

  公开（公告）日：1996-03-12

  Compounds of the formulae ##STR1## where R is cycloalkyl or aryl; R.sub.1 is alkyl, X is O or C.dbd.O; A is O or S; and B is N or CH are useful as hypoglycemic agents.

  式##STR1##中R为环烷基或芳基；R.sub.1为烷基，X为O或C.dbd.O；A为O或S；B为N或CH的化合物可用作降糖药。
• US5498621A
  申请人：——

  公开号：US5498621A

  公开（公告）日：1996-03-12